Structure

Physi-Chem Properties

Molecular Weight:  596.23
Volume:  595.494
LogP:  4.03
LogD:  3.414
LogS:  -5.097
# Rotatable Bonds:  13
TPSA:  142.37
# H-Bond Aceptor:  11
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.199
Synthetic Accessibility Score:  3.911
Fsp3:  0.344
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.163
MDCK Permeability:  2.4680937713128515e-05
Pgp-inhibitor:  0.964
Pgp-substrate:  0.705
Human Intestinal Absorption (HIA):  0.018
20% Bioavailability (F20%):  0.046
30% Bioavailability (F30%):  0.156

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  90.29399871826172%
Volume Distribution (VD):  0.33
Pgp-substrate:  20.802024841308594%

ADMET: Metabolism

CYP1A2-inhibitor:  0.068
CYP1A2-substrate:  0.912
CYP2C19-inhibitor:  0.34
CYP2C19-substrate:  0.723
CYP2C9-inhibitor:  0.85
CYP2C9-substrate:  0.816
CYP2D6-inhibitor:  0.081
CYP2D6-substrate:  0.91
CYP3A4-inhibitor:  0.511
CYP3A4-substrate:  0.909

ADMET: Excretion

Clearance (CL):  10.603
Half-life (T1/2):  0.874

ADMET: Toxicity

hERG Blockers:  0.254
Human Hepatotoxicity (H-HT):  0.199
Drug-inuced Liver Injury (DILI):  0.635
AMES Toxicity:  0.041
Rat Oral Acute Toxicity:  0.092
Maximum Recommended Daily Dose:  0.894
Skin Sensitization:  0.976
Carcinogencity:  0.037
Eye Corrosion:  0.003
Eye Irritation:  0.354
Respiratory Toxicity:  0.693

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC252402

Natural Product ID:  NPC252402
Common Name*:   (+)-9'-O-(E)-Feruloyl-5,5'-Dimethoxylariciresinol
IUPAC Name:   [(2S,3R,4R)-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]oxolan-3-yl]methyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  NTYDMYPTASSNQW-XMFFLOPHSA-N
Standard InCHI:  InChI=1S/C32H36O11/c1-37-24-11-18(6-8-23(24)33)7-9-29(34)42-17-22-21(10-19-12-25(38-2)30(35)26(13-19)39-3)16-43-32(22)20-14-27(40-4)31(36)28(15-20)41-5/h6-9,11-15,21-22,32-33,35-36H,10,16-17H2,1-5H3/b9-7+/t21-,22-,32+/m0/s1
SMILES:  COc1cc(cc(c1O)OC)[C@H]1OC[C@@H]([C@@H]1COC(=O)/C=C/c1ccc(c(c1)OC)O)Cc1cc(OC)c(c(c1)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL404050
PubChem CID:   44448269
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0003686] Furanoid lignans
        • [CHEMONTID:0001604] Tetrahydrofuran lignans
          • [CHEMONTID:0003422] 7,9'-epoxylignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18723 Zanthoxylum avicennae Species Rutaceae Eukaryota stem wood Pakuashan, Changhua County, Taiwan 2006-Jun PMID[18211005]
NPO18723 Zanthoxylum avicennae Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO18723 Zanthoxylum avicennae Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18723 Zanthoxylum avicennae Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO18723 Zanthoxylum avicennae Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 50000.0 nM PMID[553002]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 33560.0 nM PMID[553002]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC252402 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC102934
0.9571 High Similarity NPC67467
0.9452 High Similarity NPC476434
0.9396 High Similarity NPC125495
0.9388 High Similarity NPC475141
0.9324 High Similarity NPC473736
0.9247 High Similarity NPC475250
0.9205 High Similarity NPC215400
0.9205 High Similarity NPC230531
0.9189 High Similarity NPC478268
0.9128 High Similarity NPC115203
0.9128 High Similarity NPC470769
0.9078 High Similarity NPC120852
0.9078 High Similarity NPC471988
0.9071 High Similarity NPC67247
0.906 High Similarity NPC472612
0.906 High Similarity NPC472611
0.906 High Similarity NPC289967
0.9041 High Similarity NPC268515
0.9041 High Similarity NPC40222
0.9034 High Similarity NPC471415
0.9034 High Similarity NPC470097
0.9034 High Similarity NPC114119
0.9021 High Similarity NPC106055
0.9021 High Similarity NPC266197
0.9021 High Similarity NPC291101
0.9021 High Similarity NPC110699
0.9014 High Similarity NPC281780
0.9013 High Similarity NPC470827
0.9 High Similarity NPC158331
0.8986 High Similarity NPC90896
0.8986 High Similarity NPC283839
0.8986 High Similarity NPC474393
0.8986 High Similarity NPC474347
0.898 High Similarity NPC328567
0.898 High Similarity NPC327412
0.898 High Similarity NPC320671
0.898 High Similarity NPC320970
0.8974 High Similarity NPC59516
0.8973 High Similarity NPC473909
0.8973 High Similarity NPC477702
0.8973 High Similarity NPC143120
0.8973 High Similarity NPC274960
0.8954 High Similarity NPC470828
0.8947 High Similarity NPC11411
0.8936 High Similarity NPC244983
0.8936 High Similarity NPC326095
0.8936 High Similarity NPC135127
0.8936 High Similarity NPC287745
0.8933 High Similarity NPC267091
0.8929 High Similarity NPC175067
0.8929 High Similarity NPC204215
0.8926 High Similarity NPC470916
0.8912 High Similarity NPC212890
0.8912 High Similarity NPC324492
0.8912 High Similarity NPC260397
0.8912 High Similarity NPC317053
0.8903 High Similarity NPC473445
0.8889 High Similarity NPC475592
0.8882 High Similarity NPC476065
0.8873 High Similarity NPC99572
0.8873 High Similarity NPC24490
0.8873 High Similarity NPC141765
0.8873 High Similarity NPC165155
0.8873 High Similarity NPC34103
0.8873 High Similarity NPC126409
0.8867 High Similarity NPC243891
0.8859 High Similarity NPC106138
0.8859 High Similarity NPC470098
0.8859 High Similarity NPC470826
0.8859 High Similarity NPC473266
0.8846 High Similarity NPC291977
0.8844 High Similarity NPC181615
0.8844 High Similarity NPC163898
0.8836 High Similarity NPC470811
0.8836 High Similarity NPC477697
0.8836 High Similarity NPC106920
0.8836 High Similarity NPC477696
0.8836 High Similarity NPC273657
0.8831 High Similarity NPC478269
0.8819 High Similarity NPC22517
0.8811 High Similarity NPC471719
0.8811 High Similarity NPC77861
0.8808 High Similarity NPC163598
0.8808 High Similarity NPC120774
0.8808 High Similarity NPC264875
0.8808 High Similarity NPC477378
0.8808 High Similarity NPC475229
0.8805 High Similarity NPC180768
0.88 High Similarity NPC24425
0.8792 High Similarity NPC28651
0.8792 High Similarity NPC210611
0.8792 High Similarity NPC192763
0.8792 High Similarity NPC80732
0.8792 High Similarity NPC201148
0.8792 High Similarity NPC261122
0.8792 High Similarity NPC187398
0.8792 High Similarity NPC215095
0.8792 High Similarity NPC199311
0.8792 High Similarity NPC476348
0.8792 High Similarity NPC473408
0.8792 High Similarity NPC3460
0.8792 High Similarity NPC300262
0.8784 High Similarity NPC474054
0.8782 High Similarity NPC42797
0.8776 High Similarity NPC472713
0.8776 High Similarity NPC187774
0.8776 High Similarity NPC472712
0.8776 High Similarity NPC473046
0.8776 High Similarity NPC297342
0.8776 High Similarity NPC118385
0.8776 High Similarity NPC87883
0.8767 High Similarity NPC131971
0.8767 High Similarity NPC278469
0.8767 High Similarity NPC193722
0.8759 High Similarity NPC267291
0.8759 High Similarity NPC309124
0.8759 High Similarity NPC184797
0.875 High Similarity NPC126206
0.875 High Similarity NPC477377
0.875 High Similarity NPC65591
0.875 High Similarity NPC149735
0.875 High Similarity NPC178574
0.8742 High Similarity NPC324517
0.8742 High Similarity NPC329343
0.8742 High Similarity NPC321972
0.8741 High Similarity NPC93783
0.8733 High Similarity NPC176903
0.8733 High Similarity NPC125570
0.8733 High Similarity NPC30688
0.8725 High Similarity NPC295297
0.8725 High Similarity NPC476347
0.8725 High Similarity NPC39657
0.8723 High Similarity NPC470095
0.8723 High Similarity NPC470096
0.8723 High Similarity NPC474017
0.8718 High Similarity NPC478267
0.8718 High Similarity NPC149873
0.8718 High Similarity NPC7191
0.8716 High Similarity NPC83743
0.8716 High Similarity NPC476841
0.8716 High Similarity NPC476843
0.8716 High Similarity NPC287615
0.8716 High Similarity NPC216819
0.8716 High Similarity NPC262182
0.8714 High Similarity NPC83062
0.8707 High Similarity NPC469630
0.8699 High Similarity NPC470372
0.8699 High Similarity NPC83375
0.8699 High Similarity NPC224876
0.8693 High Similarity NPC268484
0.869 High Similarity NPC473739
0.869 High Similarity NPC236306
0.869 High Similarity NPC232164
0.8684 High Similarity NPC471154
0.8681 High Similarity NPC471665
0.8681 High Similarity NPC471664
0.8681 High Similarity NPC143895
0.8679 High Similarity NPC311912
0.8675 High Similarity NPC120426
0.8675 High Similarity NPC188393
0.8675 High Similarity NPC205727
0.8675 High Similarity NPC294522
0.8675 High Similarity NPC21184
0.8675 High Similarity NPC470934
0.8671 High Similarity NPC111635
0.8671 High Similarity NPC309744
0.8667 High Similarity NPC236166
0.8662 High Similarity NPC201587
0.8662 High Similarity NPC253105
0.8654 High Similarity NPC476373
0.8652 High Similarity NPC145305
0.8652 High Similarity NPC241522
0.8652 High Similarity NPC42300
0.8652 High Similarity NPC242807
0.8652 High Similarity NPC153739
0.8652 High Similarity NPC92164
0.8652 High Similarity NPC187998
0.8652 High Similarity NPC257582
0.8652 High Similarity NPC77040
0.8652 High Similarity NPC64201
0.8652 High Similarity NPC174495
0.8649 High Similarity NPC110063
0.8643 High Similarity NPC184733
0.8643 High Similarity NPC45774
0.8643 High Similarity NPC282703
0.8643 High Similarity NPC11258
0.8643 High Similarity NPC21867
0.8643 High Similarity NPC129570
0.8643 High Similarity NPC109275
0.8643 High Similarity NPC128208
0.8639 High Similarity NPC5262
0.8639 High Similarity NPC287124
0.8639 High Similarity NPC472714
0.8639 High Similarity NPC107161
0.8639 High Similarity NPC140502
0.863 High Similarity NPC160283
0.863 High Similarity NPC254759
0.863 High Similarity NPC177868
0.8627 High Similarity NPC297271

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC252402 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8582 High Similarity NPD3027 Phase 3
0.8471 Intermediate Similarity NPD6234 Discontinued
0.8344 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD37 Approved
0.8228 Intermediate Similarity NPD4966 Approved
0.8228 Intermediate Similarity NPD4965 Approved
0.8228 Intermediate Similarity NPD4967 Phase 2
0.8221 Intermediate Similarity NPD7228 Approved
0.8188 Intermediate Similarity NPD7266 Discontinued
0.8151 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8151 Intermediate Similarity NPD1613 Approved
0.8129 Intermediate Similarity NPD1653 Approved
0.8065 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD7199 Phase 2
0.8 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD7473 Discontinued
0.7931 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD1934 Approved
0.7892 Intermediate Similarity NPD3818 Discontinued
0.7879 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD6166 Phase 2
0.7877 Intermediate Similarity NPD4908 Phase 1
0.7866 Intermediate Similarity NPD6232 Discontinued
0.7857 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD6190 Approved
0.7844 Intermediate Similarity NPD5844 Phase 1
0.7778 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3882 Suspended
0.777 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD3817 Phase 2
0.7706 Intermediate Similarity NPD7240 Approved
0.7706 Intermediate Similarity NPD7685 Pre-registration
0.7697 Intermediate Similarity NPD8127 Discontinued
0.7692 Intermediate Similarity NPD7074 Phase 3
0.7661 Intermediate Similarity NPD7549 Discontinued
0.7654 Intermediate Similarity NPD2801 Approved
0.7654 Intermediate Similarity NPD1465 Phase 2
0.7633 Intermediate Similarity NPD7054 Approved
0.7622 Intermediate Similarity NPD7075 Discontinued
0.7616 Intermediate Similarity NPD230 Phase 1
0.7588 Intermediate Similarity NPD7472 Approved
0.7572 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD8166 Discontinued
0.7561 Intermediate Similarity NPD7768 Phase 2
0.755 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD4060 Phase 1
0.755 Intermediate Similarity NPD3620 Phase 2
0.7546 Intermediate Similarity NPD7819 Suspended
0.7534 Intermediate Similarity NPD2982 Phase 2
0.7534 Intermediate Similarity NPD2983 Phase 2
0.753 Intermediate Similarity NPD5494 Approved
0.7517 Intermediate Similarity NPD1610 Phase 2
0.75 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5283 Phase 1
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6559 Discontinued
0.7486 Intermediate Similarity NPD7680 Approved
0.7469 Intermediate Similarity NPD4380 Phase 2
0.7467 Intermediate Similarity NPD7095 Approved
0.7466 Intermediate Similarity NPD2981 Phase 2
0.7457 Intermediate Similarity NPD7808 Phase 3
0.7457 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD4628 Phase 3
0.7452 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD3018 Phase 2
0.745 Intermediate Similarity NPD2861 Phase 2
0.7439 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD4357 Discontinued
0.7421 Intermediate Similarity NPD1511 Approved
0.7417 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD7251 Discontinued
0.7397 Intermediate Similarity NPD422 Phase 1
0.7397 Intermediate Similarity NPD3705 Approved
0.7389 Intermediate Similarity NPD1652 Phase 2
0.7386 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD5124 Phase 1
0.7386 Intermediate Similarity NPD6355 Discontinued
0.7368 Intermediate Similarity NPD6233 Phase 2
0.7363 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7357 Intermediate Similarity NPD228 Approved
0.7342 Intermediate Similarity NPD3750 Approved
0.7342 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD4110 Phase 3
0.7341 Intermediate Similarity NPD6797 Phase 2
0.7337 Intermediate Similarity NPD7229 Phase 3
0.7329 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD1512 Approved
0.7317 Intermediate Similarity NPD7411 Suspended
0.7305 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD3764 Approved
0.7303 Intermediate Similarity NPD6798 Discontinued
0.7292 Intermediate Similarity NPD5536 Phase 2
0.7289 Intermediate Similarity NPD5402 Approved
0.7278 Intermediate Similarity NPD6674 Discontinued
0.7273 Intermediate Similarity NPD6801 Discontinued
0.7267 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD5763 Approved
0.7261 Intermediate Similarity NPD5762 Approved
0.7251 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD1548 Phase 1
0.7229 Intermediate Similarity NPD8455 Phase 2
0.7226 Intermediate Similarity NPD6653 Approved
0.7215 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD3021 Approved
0.7214 Intermediate Similarity NPD3022 Approved
0.7208 Intermediate Similarity NPD4140 Approved
0.7205 Intermediate Similarity NPD6799 Approved
0.7197 Intermediate Similarity NPD2935 Discontinued
0.7195 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD5242 Approved
0.719 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD5353 Approved
0.7181 Intermediate Similarity NPD4749 Approved
0.7179 Intermediate Similarity NPD7097 Phase 1
0.7178 Intermediate Similarity NPD5403 Approved
0.717 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD4340 Discontinued
0.716 Intermediate Similarity NPD2533 Approved
0.716 Intermediate Similarity NPD2532 Approved
0.716 Intermediate Similarity NPD2534 Approved
0.7152 Intermediate Similarity NPD6599 Discontinued
0.7134 Intermediate Similarity NPD1510 Phase 2
0.7126 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD4625 Phase 3
0.7119 Intermediate Similarity NPD8313 Approved
0.7119 Intermediate Similarity NPD8312 Approved
0.7117 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD1549 Phase 2
0.7101 Intermediate Similarity NPD6971 Discontinued
0.7101 Intermediate Similarity NPD3749 Approved
0.7095 Intermediate Similarity NPD8434 Phase 2
0.7093 Intermediate Similarity NPD3926 Phase 2
0.7086 Intermediate Similarity NPD2797 Approved
0.7076 Intermediate Similarity NPD6959 Discontinued
0.7075 Intermediate Similarity NPD1357 Approved
0.7071 Intermediate Similarity NPD1358 Approved
0.7063 Intermediate Similarity NPD7843 Approved
0.7063 Intermediate Similarity NPD5535 Approved
0.7059 Intermediate Similarity NPD919 Approved
0.7055 Intermediate Similarity NPD5401 Approved
0.7055 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5735 Approved
0.7044 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7124 Phase 2
0.7034 Intermediate Similarity NPD7157 Approved
0.7033 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD4626 Approved
0.7025 Intermediate Similarity NPD3748 Approved
0.7012 Intermediate Similarity NPD6273 Approved
0.7006 Intermediate Similarity NPD7039 Approved
0.7006 Intermediate Similarity NPD7038 Approved
0.7006 Intermediate Similarity NPD6386 Approved
0.7006 Intermediate Similarity NPD6385 Approved
0.7 Intermediate Similarity NPD1608 Approved
0.7 Intermediate Similarity NPD3134 Approved
0.6993 Remote Similarity NPD5736 Approved
0.6993 Remote Similarity NPD9494 Approved
0.6988 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4005 Discontinued
0.6987 Remote Similarity NPD1558 Phase 1
0.6987 Remote Similarity NPD1240 Approved
0.6983 Remote Similarity NPD8053 Approved
0.6983 Remote Similarity NPD8054 Approved
0.6981 Remote Similarity NPD1551 Phase 2
0.6981 Remote Similarity NPD2438 Suspended
0.6981 Remote Similarity NPD6100 Approved
0.6981 Remote Similarity NPD2796 Approved
0.6981 Remote Similarity NPD6099 Approved
0.698 Remote Similarity NPD3496 Discontinued
0.6968 Remote Similarity NPD3268 Approved
0.6964 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7906 Approved
0.6959 Remote Similarity NPD5691 Approved
0.6957 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6957 Remote Similarity NPD4236 Phase 3
0.6957 Remote Similarity NPD4237 Approved
0.6951 Remote Similarity NPD7447 Phase 1
0.6951 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6946 Remote Similarity NPD4675 Approved
0.6946 Remote Similarity NPD4678 Approved
0.6943 Remote Similarity NPD447 Suspended
0.6937 Remote Similarity NPD3540 Phase 1
0.6937 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6933 Remote Similarity NPD5058 Phase 3
0.6928 Remote Similarity NPD3686 Approved
0.6928 Remote Similarity NPD6584 Phase 3
0.6928 Remote Similarity NPD3687 Approved
0.6923 Remote Similarity NPD2977 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data